Literature DB >> 791101

Comparison of thrombophlebitis associated with three cephalosporin antibiotics.

W T Siebert, E L Westerman, J D Smilack, M W Bradshaw, T W Williams.   

Abstract

A double-blind study with volunteers was performed to determine the incidence and severity of thrombophlebitis associated with cephalothin, cephapirin, cefamandole, and a water control. Although there were no statistical differences in the incidence of thrombophlebitis, cephalothin resulted in significantly more severe thrombophlebitis compared with the other agents.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791101      PMCID: PMC429773          DOI: 10.1128/AAC.10.3.467

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Phlebitis associated with cephalosporins: cephapirin versus cephalothin.

Authors:  J Inagaki; G P Bodey
Journal:  Curr Ther Res Clin Exp       Date:  1973-02

2.  Clinical manifestations of chancroid.

Authors:  G Storey
Journal:  Br J Urol       Date:  1970-12

3.  Experiences with cephalothin.

Authors:  R L Perkins; S Saslaw
Journal:  Ann Intern Med       Date:  1966-01       Impact factor: 25.391

4.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

5.  Cephapirin: in vitro antibacterial spectrum.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  Appl Microbiol       Date:  1971-11

6.  Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin.

Authors:  J Carrizosa; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

7.  Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.

Authors:  A Z Lane; J G Taggart; R L Iles
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.